Sandy Van Hemelryck
5PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Feb 27, 2026
In Vitro Evaluation of Poly(D,L-lactide-co-glycolide) In Situ Gels and Pharmacokinetics Following Subcutaneous Injection in Rats for Model Drugs.Sandy Van Hemelryck, Charlotte Vercammen, Eline Seldeslachts
|Jun 16, 2025
Pediatric darunavir/cobicistat fixed-dose combination tablet for dispersion: Bioequivalence versus separate agents in healthy participants and acceptability in children living with human immunodeficiency virus-1.Sandy Van Hemelryck, Erika Van Landuyt, Sofie Deleu
|May 10, 2024
Assessment of swallowability and acceptability of scored darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) fixed-dose combination (FDC) tablets in HIV-1-infected children aged ≥6 to <12 years, using matching placebo tablets: A randomized study.Sandy Van Hemelryck, Erika Van Landuyt, Veerle Hufkens
|Aug 28, 2021
In Vitro Evaluation of Poly(lactide-co-glycolide) In Situ Forming Gels for Bedaquiline Fumarate Salt and Pharmacokinetics Following Subcutaneous Injection in Rats.Sandy Van Hemelryck, Rani Wens, Hannelore van Poppel
|May 26, 2018
Preclinical Bioavailability Strategy for Decisions on Clinical Drug Formulation Development: An In Depth Analysis.An Van den Bergh, Sandy Van Hemelryck, Jan Bevernage
Pageof 1
